iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) Hits New 12-Month High – What’s Next?

iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE)’s share price reached a new 52-week high on Monday . The stock traded as high as $86.28 and last traded at $86.0510, with a volume of 134653 shares changing hands. The stock had previously closed at $84.81.

iShares U.S. Pharmaceuticals ETF Price Performance

The firm has a market cap of $677.01 million, a PE ratio of 17.75 and a beta of 0.54. The business has a 50-day moving average price of $79.30 and a two-hundred day moving average price of $72.40.

Institutional Trading of iShares U.S. Pharmaceuticals ETF

Several institutional investors and hedge funds have recently modified their holdings of the business. National Bank of Canada FI grew its position in shares of iShares U.S. Pharmaceuticals ETF by 42.7% in the third quarter. National Bank of Canada FI now owns 585 shares of the company’s stock valued at $42,000 after purchasing an additional 175 shares during the last quarter. Wealthcare Advisory Partners LLC lifted its stake in iShares U.S. Pharmaceuticals ETF by 4.3% in the 2nd quarter. Wealthcare Advisory Partners LLC now owns 4,898 shares of the company’s stock valued at $321,000 after buying an additional 201 shares in the last quarter. Raab & Moskowitz Asset Management LLC grew its holdings in iShares U.S. Pharmaceuticals ETF by 4.4% during the 1st quarter. Raab & Moskowitz Asset Management LLC now owns 4,803 shares of the company’s stock valued at $339,000 after buying an additional 204 shares during the last quarter. PNC Financial Services Group Inc. grew its holdings in iShares U.S. Pharmaceuticals ETF by 20.3% during the 1st quarter. PNC Financial Services Group Inc. now owns 1,281 shares of the company’s stock valued at $90,000 after buying an additional 216 shares during the last quarter. Finally, Arkansas Financial Group Inc. increased its position in iShares U.S. Pharmaceuticals ETF by 3.2% during the third quarter. Arkansas Financial Group Inc. now owns 7,415 shares of the company’s stock worth $561,000 after buying an additional 230 shares in the last quarter.

iShares U.S. Pharmaceuticals ETF Company Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.